Literature DB >> 2215512

Interleukin-2, killer cells and cancer therapy: an overview.

D R Parkinson1, E Lotzová.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2215512

Source DB:  PubMed          Journal:  Nat Immun Cell Growth Regul        ISSN： 0254-7600


× No keyword cloud information.
  2 in total

1.  Tyrosine kinase-dependent and -independent events induced by interleukin-2 stimulation: interleukin-2-mediated NO production required for the induction of lymphokine-activated killer cell activity in rat splenocytes is tyrosine kinase independent.

Authors:  A Juretic; G C Spagnoli; H Hörig; R Shipman; T Kocher; M Samija; M Turic; D Eljuga; F Harder; M Heberer
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

2.  ToxiM: A Toxicity Prediction Tool for Small Molecules Developed Using Machine Learning and Chemoinformatics Approaches.

Authors:  Ashok K Sharma; Gopal N Srivastava; Ankita Roy; Vineet K Sharma
Journal:  Front Pharmacol       Date:  2017-11-30       Impact factor: 5.810
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.